<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40806149</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>15</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>06</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Long-Term Outcomes of the Dietary Approaches to Stop Hypertension (DASH) Intervention in Nonobstructive Coronary Artery Disease: Follow-Up of the DISCO-CT Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2565</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu17152565</ELocationID><Abstract><AbstractText Label="UNLABELLED">In the original randomised Dietary Intervention to Stop Coronary Atherosclerosis (DISCO-CT) trial, a 12-month Dietary Approaches to Stop Hypertension (DASH) project led by dietitians improved cardiovascular and metabolic risk factors and reduced platelet chemokine levels in patients with coronary artery disease (CAD). It is unclear whether these benefits are sustained.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine whether the metabolic, inflammatory, and clinical benefits achieved during the DISCO-CT trial are sustained six years after the structured intervention ended.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Ninety-seven adults with non-obstructive CAD confirmed in coronary computed tomography angiography were randomly assigned to receive optimal medical therapy (control group, <i>n</i> = 41) or the same therapy combined with intensive DASH counselling (DASH group, <i>n</i> = 43). After 301 &#xb1; 22 weeks, 84 individuals (87%) who had given consent underwent reassessment of body composition, meal frequency assessment, and biochemical testing (lipids, hs-CRP, CXCL4, RANTES and homocysteine). Major adverse cardiovascular events (MACE) were assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During the intervention, the DASH group lost an average of 3.6 &#xb1; 4.2 kg and reduced their total body fat by an average of 4.2 &#xb1; 4.8 kg, compared to an average loss of 1.1 &#xb1; 2.9 kg and a reduction in total body fat of 0.3 &#xb1; 4.1 kg in the control group (both <i>p</i> &lt; 0.01). Six years later, most of the lost body weight and fat tissue had been regained, and there was a sharp increase in visceral fat area in both groups (<i>p</i> &lt; 0.0001). CXCL4 decreased by 4.3 &#xb1; 3.0 ng/mL during the intervention and remained lower than baseline values; in contrast, in the control group, it initially increased and then decreased (<i>p</i> &lt; 0.001 between groups). LDL cholesterol and hs-CRP levels returned to baseline in both groups but remained below baseline in the DASH group. There was one case of MACE in the DASH group, compared with four cases (including one fatal myocardial infarction) in the control group (<i>p</i> = 0.575). Overall adherence to the DASH project increased by 26 points during counselling and then decreased by only four points, remaining higher than in the control group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A one-year DASH project supported by a physician and dietitian resulted in long-term suppression of the proatherogenic chemokine CXCL4 and fewer MACE over six years, despite a decline in adherence and loss of most anthropometric and lipid benefits. It appears that sustained systemic reinforcement of behaviours is necessary to maintain the benefits of lifestyle intervention in CAD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Makarewicz-Wujec</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4330-3007</Identifier><AffiliationInfo><Affiliation>Institute of Pharmaceutical Care, VIZJA University, Okopowa Street 59, 01-043 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henzel</LastName><ForeName>Jan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9619-2718</Identifier><AffiliationInfo><Affiliation>Department of Coronary and Structural Heart Diseases, National Institute of Cardiology, 42 Alpejska Street, 04-628 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#x119;pka</LastName><ForeName>Cezary</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Coronary and Structural Heart Diseases, National Institute of Cardiology, 42 Alpejska Street, 04-628 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kruk</LastName><ForeName>Mariusz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Coronary and Structural Heart Diseases, National Institute of Cardiology, 42 Alpejska Street, 04-628 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jakubczak</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Medical Diagnostic Laboratory, National Institute of Cardiology, 42 Alpejska Street, 04-628 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wr&#xf3;bel</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Diagnostic Laboratory, National Institute of Cardiology, 42 Alpejska Street, 04-628 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#x105;browski</LastName><ForeName>Rafa&#x142;</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Coronary Artery Disease and Cardiac Rehabilitation, National Institute of Cardiology, 42 Alpejska Street, 04-628 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dzieli&#x144;ska</LastName><ForeName>Zofia</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Coronary and Structural Heart Diseases, National Institute of Cardiology, 42 Alpejska Street, 04-628 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demkow</LastName><ForeName>Marcin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Coronary and Structural Heart Diseases, National Institute of Cardiology, 42 Alpejska Street, 04-628 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Czepielewska</LastName><ForeName>Edyta</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-3149-239X</Identifier><AffiliationInfo><Affiliation>Institute of Pharmaceutical Care, VIZJA University, Okopowa Street 59, 01-043 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filipek</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1351-3687</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical Biology, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2.15/III/15</GrantID><Agency>Institute of Cardiology in Warsaw, Poland.</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="Y">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000178" MajorTopicYN="N">diet therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073601" MajorTopicYN="Y">Dietary Approaches To Stop Hypertension</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName><QualifierName UI="Q000178" MajorTopicYN="N">diet therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001823" MajorTopicYN="N">Body Composition</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DASH diet</Keyword><Keyword MajorTopicYN="N">chemokines CXCL4 and RANTES</Keyword><Keyword MajorTopicYN="N">coronary artery diseases</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>31</Day><Hour>20</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40806149</ArticleId><ArticleId IdType="pmc">PMC12348568</ArticleId><ArticleId IdType="doi">10.3390/nu17152565</ArticleId><ArticleId IdType="pii">nu17152565</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mensah G.A., Fuster V., Murray C.J.L., Roth G.A., Global Burden of Cardiovascular Diseases and Risks Collaborators Global Burden of Cardiovascular Diseases and Risk Factors, 1990&#x2013;2022. J. Am. Coll. Cardiol. 2023;82:2374&#x2013;2390. doi: 10.1016/j.jacc.2023.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2023.11.007</ArticleId><ArticleId IdType="pmc">PMC7615984</ArticleId><ArticleId IdType="pubmed">38092509</ArticleId></ArticleIdList></Reference><Reference><Citation>Laffond A., Rivera-Pic&#xf3;n C., Rodr&#xed;guez-Mu&#xf1;oz P.M., Ju&#xe1;rez-Vela R., Ruiz de Vi&#xf1;aspre-Hern&#xe1;ndez R., Navas-Echazarreta N., S&#xe1;nchez-Gonz&#xe1;lez J.L. Mediterranean Diet for Primary and Secondary Prevention of Cardiovascular Disease and Mortality: An Updated Systematic Review. Nutrients. 2023;15:3356. doi: 10.3390/nu15153356.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15153356</ArticleId><ArticleId IdType="pmc">PMC10421390</ArticleId><ArticleId IdType="pubmed">37571293</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiavaroli L., Nishi S.K., Khan T.A., Braunstein C.R., Glenn A.J., Mejia S.B., Raheli&#x107; D., Kahleov&#xe1; H., Salas-Salvad&#xf3; J., Jenkins D.J.A., et al. Portfolio Dietary Pattern and Cardiovascular Disease: A Systematic Review and Meta-Analysis of Controlled Trials. Prog. Cardiovasc. Dis. 2018;61:43&#x2013;53. doi: 10.1016/j.pcad.2018.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2018.05.004</ArticleId><ArticleId IdType="pubmed">29807048</ArticleId></ArticleIdList></Reference><Reference><Citation>Visseren F.L.J., Mach F., Smulders Y.M., Carballo D., Koskinas K.C., B&#xe4;ck M., Benetos A., Biffi A., Boavida J.M., Capodanno D., et al. 2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Eur. Heart J. 2021;42:3227&#x2013;3337. doi: 10.1093/eurheartj/ehab484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab484</ArticleId><ArticleId IdType="pubmed">34458905</ArticleId></ArticleIdList></Reference><Reference><Citation>Appel L.J., Moore T.J., Obarzanek E., Vollmer W.M., Svetkey L.P., Sacks F.M., Bray G.A., Vogt T.M., Cutler J.A., Windhauser M.M., et al. Clinical Trial of the Effects of Dietary Patterns on Blood Pressure. N. Engl. J. Med. 1997;336:1117&#x2013;1124. doi: 10.1056/NEJM199704173361601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199704173361601</ArticleId><ArticleId IdType="pubmed">9099655</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacks F.M., Svetkey L.P., Vollmer W.M., Appel L.J., Bray G.A., Harsha D., Obarzanek E., Conlin P.R., Miller E.R., III, Simons-Morton D.G., et al. Effects on Blood Pressure of Reduced Dietary Sodium and the DASH Diet. N. Engl. J. Med. 2001;344:3&#x2013;10. doi: 10.1056/NEJM200101043440101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200101043440101</ArticleId><ArticleId IdType="pubmed">11136953</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiavaroli L., Viguiliouk E., Nishi S.K., Blanco Mejia S., Raheli&#x107; D., Kahleov&#xe1; H., Salas-Salvad&#xf3; J., Kendall C.W.C., Sievenpiper J.L. DASH Dietary Pattern and Cardiometabolic Outcomes: An Umbrella Review of Systematic Reviews and Meta-Analyses. Nutrients. 2019;11:338. doi: 10.3390/nu11020338.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11020338</ArticleId><ArticleId IdType="pmc">PMC6413235</ArticleId><ArticleId IdType="pubmed">30764511</ArticleId></ArticleIdList></Reference><Reference><Citation>Lari A., Sohouli M.H., Fatahi S., Cerqueira H.S., Santos H.O., Pourrajab B., Rezaei M. The Effects of the Dietary Approaches to Stop Hypertension (DASH) Diet on Metabolic Risk Factors in Patients with Chronic Disease: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Nutr. Metab. Cardiovasc. Dis. 2021;31:2766&#x2013;2778. doi: 10.1016/j.numecd.2021.05.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2021.05.030</ArticleId><ArticleId IdType="pubmed">34353704</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z.Q., Yang Z., Duan M.L. DASH Diet and Risk of Coronary Artery Disease: A Meta-Analysis of Prospective Cohort Studies. Int. J. Food Sci. Nutr. 2019;70:668&#x2013;674. doi: 10.1080/09637486.2019.1570490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09637486.2019.1570490</ArticleId><ArticleId IdType="pubmed">30810409</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibsen D.B., Levitan E.B., &#xc5;kesson A., Gigante B., Wolk A. The DASH Diet Is Associated with a Lower Risk of Heart Failure: A Cohort Study. Eur. J. Prev. Cardiol. 2022;29:1114&#x2013;1123. doi: 10.1093/eurjpc/zwac003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurjpc/zwac003</ArticleId><ArticleId IdType="pubmed">34983068</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensaaud A., Seery S., Gibson I., Jones J., Flaherty G., McEvoy J.W., Jordan F., Tawfick W., Sultan S.A. Dietary Approaches to Stop Hypertension (DASH) for the Primary and Secondary Prevention of Cardiovascular Diseases. Cochrane Database Syst. Rev. 2025;5:CD013729. doi: 10.1002/14651858.cd013729.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.cd013729.pub2</ArticleId><ArticleId IdType="pmc">PMC12053460</ArticleId><ArticleId IdType="pubmed">40326569</ArticleId></ArticleIdList></Reference><Reference><Citation>Siervo M., Lara J., Chowdhury S., Ashor A., Oggioni C., Mathers J.C. Effects of the Dietary Approach to Stop Hypertension (DASH) Diet on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis. Br. J. Nutr. 2015;113:1&#x2013;15. doi: 10.1017/S0007114514003341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114514003341</ArticleId><ArticleId IdType="pubmed">25430608</ArticleId></ArticleIdList></Reference><Reference><Citation>Aleksandrova K., Koelman L., Rodrigues C.E. Dietary Patterns and Biomarkers of Oxidative Stress and Inflammation: A Systematic Review of Observational and Intervention Studies. Redox Biol. 2021;42:101869. doi: 10.1016/j.redox.2021.101869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.101869</ArticleId><ArticleId IdType="pmc">PMC8113044</ArticleId><ArticleId IdType="pubmed">33541846</ArticleId></ArticleIdList></Reference><Reference><Citation>Makarewicz-Wujec M., Henzel J., Kruk M., K&#x119;pka C., Wardziak &#x141;., Trochimiuk P., Parzonko A., Demkow M., Dzieli&#x144;ska Z., Koz&#x142;owska-Wojciechowska M. The Effect of Intensive Dietary Intervention Lowers RANTES and CXCL4 in Non-Obstructive Coronary Disease: A Randomised Study. Biology. 2021;10:156. doi: 10.3390/biology10020156.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology10020156</ArticleId><ArticleId IdType="pmc">PMC7920478</ArticleId><ArticleId IdType="pubmed">33669450</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleissner C.A., Shaked I., Little K.M., Ley K., Randolph G.J. CXCL4 Down-Regulates the Atheroprotective Hemoglobin Scavenger Receptor CD163 in Human Macrophages. Circ. Res. 2010;106:203&#x2013;211. doi: 10.1161/CIRCRESAHA.109.199505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.109.199505</ArticleId><ArticleId IdType="pmc">PMC2876722</ArticleId><ArticleId IdType="pubmed">19910578</ArticleId></ArticleIdList></Reference><Reference><Citation>Domschke G., Gleissner C.A. CXCL4-Induced Macrophages in Human Atherosclerosis. Cytokine. 2019;122:154141. doi: 10.1016/j.cyto.2017.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2017.08.021</ArticleId><ArticleId IdType="pubmed">28899579</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin P.-H., Appel L.J., Funk K., Craddick S., Chen C., Elmer P., McBurnie M.A., Champagne C. The PREMIER Intervention Helps Participants Follow the Dietary Approaches to Stop Hypertension Dietary Pattern and the Current Dietary Reference Intakes Recommendations. J. Am. Diet. Assoc. 2007;107:1541&#x2013;1551. doi: 10.1016/j.jada.2007.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jada.2007.06.019</ArticleId><ArticleId IdType="pubmed">17761231</ArticleId></ArticleIdList></Reference><Reference><Citation>Henzel J., K&#x119;pka C., Kruk M., Makarewicz-Wujec M., Wardziak &#x141;., Trochimiuk P., Dzieli&#x144;ska Z., Demkow M. High-Risk Coronary Plaque Regression after Intensive Lifestyle Intervention in Non-Obstructive Coronary Disease: A Randomised Study. JACC Cardiovasc. Imaging. 2021;14:1192&#x2013;1202. doi: 10.1016/j.jcmg.2020.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.10.019</ArticleId><ArticleId IdType="pubmed">33341413</ArticleId></ArticleIdList></Reference><Reference><Citation>Makarewicz-Wujec M., Henzel J., K&#x119;pka C., Kruk M., Wardziak &#x141;., Trochimiuk P., Parzonko A., Dzieli&#x144;ska Z., Demkow M., Koz&#x142;owska-Wojciechowska M. Usefulness of MCP-1 Chemokine in Monitoring Patients with Coronary Artery Disease Subjected to Intensive Dietary Intervention: A Pilot Study. Nutrients. 2021;13:3047. doi: 10.3390/nu13093047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13093047</ArticleId><ArticleId IdType="pmc">PMC8467171</ArticleId><ArticleId IdType="pubmed">34578925</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nther A.L., Liese A.D., Bell R.A., Dabelea D., Lawrence J.M., Rodriguez B.L., Standiford D.A., Mayer-Davis E.J. Association between the Dietary Approaches to Hypertension Diet and Hypertension in Youth with Diabetes Mellitus. Hypertension. 2009;53:6&#x2013;12. doi: 10.1161/HYPERTENSIONAHA.108.116665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.108.116665</ArticleId><ArticleId IdType="pmc">PMC7732209</ArticleId><ArticleId IdType="pubmed">19029488</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonekamp N.E., Cruijsen E., Geleijnse J.M., Winkels R.M., Visseren F.L.J., Morris P.B., Koopal C. Diet in Secondary Prevention: The Effect of Dietary Patterns on Cardiovascular Risk Factors in Patients with Cardiovascular Disease&#x2014;A Systematic Review and Network Meta-Analysis. Nutr. J. 2024;23:18. doi: 10.1186/s12937-024-00922-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12937-024-00922-8</ArticleId><ArticleId IdType="pmc">PMC10851459</ArticleId><ArticleId IdType="pubmed">38331867</ArticleId></ArticleIdList></Reference><Reference><Citation>Cesaro A., De Michele G., Fimiani F., Acerbo V., Scherillo G., Signore G., Rotolo F.P., Scialla F., Raucci G., Panico D., et al. Visceral Adipose Tissue and Residual Cardiovascular Risk: A Pathological Link and New Therapeutic Options. Front. Cardiovasc. Med. 2023;10:1187735. doi: 10.3389/fcvm.2023.1187735.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1187735</ArticleId><ArticleId IdType="pmc">PMC10421666</ArticleId><ArticleId IdType="pubmed">37576108</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucharska A., Si&#x144;ska B., Panczyk M., Szostak-W&#x119;gierek D., Raciborski F., Samoli&#x144;ski B., Borowicz J., Wronka L., Traczyk I. Diet and Selected Elements of Lifestyle in the Polish Population before and during the COVID-19 Pandemic&#x2014;A Population Study. Ann. Agric. Environ. Med. 2023;30:118&#x2013;126. doi: 10.26444/aaem/156939.</Citation><ArticleIdList><ArticleId IdType="doi">10.26444/aaem/156939</ArticleId><ArticleId IdType="pubmed">36999864</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyle&#x17c;o&#x142; M., Si&#x144;ska B.I., Kucharska A., Panczyk M., Raciborski F., Szostak-W&#x119;gierek D., Milewska M., Samoli&#x144;ski B., Fr&#x105;czek M., Traczyk I. The Influence of Obesity on Nutrition and Physical Activity during the COVID-19 Pandemic: A Case-Control Study. Nutrients. 2022;14:2236. doi: 10.3390/nu14112236.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14112236</ArticleId><ArticleId IdType="pmc">PMC9183150</ArticleId><ArticleId IdType="pubmed">35684036</ArticleId></ArticleIdList></Reference><Reference><Citation>Soltani S., Chitsazi M.J., Salehi-Abargouei A. The Effect of Dietary Approaches to Stop Hypertension on Serum Inflammatory Markers: A Systematic Review and Meta-Analysis of Randomised Trials. Clin. Nutr. 2018;37:542&#x2013;550. doi: 10.1016/j.clnu.2017.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2017.02.018</ArticleId><ArticleId IdType="pubmed">28302405</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachais B.S., Turrentine T., Dawicki-McKenna J.M. Elimination of platelet factor 4 from platelets reduces atherosclerosis in ApoE-/- mice. Thromb. Haemost. 2007;98:1108&#x2013;1113.</Citation><ArticleIdList><ArticleId IdType="pubmed">18000617</ArticleId></ArticleIdList></Reference><Reference><Citation>von Hundelshausen P., Koenen R.R., Sack M., Mause S.F., Adriaens W., Proudfoot A.E., Hackeng T.M., Weber C. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood. 2005;105:924&#x2013;930. doi: 10.1182/blood-2004-06-2475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2004-06-2475</ArticleId><ArticleId IdType="pubmed">15459010</ArticleId></ArticleIdList></Reference><Reference><Citation>Versteylen M.O., Manca M., Joosen I.A., Schmidt D.E., Das M., Hofstra L., Crijns H.J., Biessen E.A., Kietselaer B.L. CC Chemokine Ligands in Patients Presenting with Stable Chest Pain: Association with Atherosclerosis and Future Cardiovascular Events. Neth. Heart J. 2016;24:722&#x2013;729. doi: 10.1007/s12471-016-0884-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12471-016-0884-9</ArticleId><ArticleId IdType="pmc">PMC5120005</ArticleId><ArticleId IdType="pubmed">27573044</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazidi M., Rezaie P., Ferns G.A., Gao H.K. Impact of Different Types of Tree Nut, Peanut, and Soy Nut Consumption on Serum C-Reactive Protein: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Medicine. 2016;95:e5165. doi: 10.1097/MD.0000000000005165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000005165</ArticleId><ArticleId IdType="pmc">PMC5591098</ArticleId><ArticleId IdType="pubmed">27858850</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi X., Li Y., Fang C., Jia Y., Chen M., Chen X., Jia J. The Associations between Dietary Fibres Intake and Systemic Immune and Inflammatory Biomarkers: A Multi-Cycle Study of NHANES 2015&#x2013;2020. Front. Nutr. 2023;10:1242115. doi: 10.3389/fnut.2023.1242115.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2023.1242115</ArticleId><ArticleId IdType="pmc">PMC10501836</ArticleId><ArticleId IdType="pubmed">37720377</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellmann B., Lin T., Greissinger K., Rottner L., Rillig A., Zimmerling S. The Beneficial Effects of Cardiac Rehabilitation. Cardiol. Ther. 2020;9:35&#x2013;44. doi: 10.1007/s40119-020-00164-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40119-020-00164-9</ArticleId><ArticleId IdType="pmc">PMC7237601</ArticleId><ArticleId IdType="pubmed">31997145</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz-Cobo C., Brezmes L., Altadill M., Garc&#xed;a-Garc&#xed;a H., Gheorghe L.L., Guti&#xe9;rrez-Barrios A., Ca&#xf1;adas D., Tur J.A., V&#xe1;zquez-Garc&#xed;a R., Santi-Cano M.J. Efficacy of a Mobile Health App (eMOTIVA) Regarding Compliance with Cardiac Rehabilitation Guidelines in Coronary Artery Disease: Randomised Controlled Trial. JMIR mHealth uHealth. 2024;12:e55421. doi: 10.2196/55421.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/55421</ArticleId><ArticleId IdType="pmc">PMC11310647</ArticleId><ArticleId IdType="pubmed">39052330</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishio R., Dohi T., Yokoyama M., Nakade T., Takahashi N., Chikata Y., Endo H., Nishiyama H., Okai I., Iwata H., et al. Wearable Devices in Remote Cardiac Rehabilitation with and without Weekly Online Coaching for Coronary Artery Disease: Randomised Controlled Trial. JMIR mHealth uHealth. 2025;13:e63797. doi: 10.2196/63797.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/63797</ArticleId><ArticleId IdType="pmc">PMC12088619</ArticleId><ArticleId IdType="pubmed">40395066</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>